Editorial Open Access
Volume 1 | Issue 2 | DOI: https://doi.org/10.33696/Pharmacol.1.010
Admitting UnKnown Biosimilar- Drugs Affects Thrombosis and Haemostasis Processes
Bahram Alamdary Badlou1,*
- 1Department of Research and Development, BBAdvies and Research, 3706XA, Zeist, The Netherlands
Corresponding Author
Bahram Alamdary Badlou, bbadlou@casema.nl
Received Date: November 29, 2019
Accepted Date: December 09, 2019
Citation:
Badlou BA. Admitting (Un)Known (Biosimilar-) Drugs Affects Thrombosis and Haemostasis Processes. Arch Pharmacol Ther. 2019; 1(2):57-58.
Copyright: © 2019 Badlou BA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.